Results 171 to 180 of about 63,989 (248)

Economic evaluation of direct oral anticoagulants (DOACs) for venous thromboembolism with different etiologies: a systematic review. [PDF]

Health Econ Rev
Karimi F, Rajaie S, Azari S, Abbaszadeh MS, Karimi Z.   +4 more
europepmc   +1 more source

JAK inhibitors in livedoid vasculopathy associated with thrombophilia and refractory to anticoagulation: report and literature review. [PDF]

An Bras Dermatol
Criado GJ, Criado PR, Lorenzini D, Miot HA.   +3 more
europepmc   +1 more source

Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers. [PDF]

Res Pract Thromb Haemost
Kumar R, Drake E, Stanek J, Yeager N, Vrooman LM, Silverman LB, Rodriguez V.   +6 more
europepmc   +1 more source

Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. [PDF]

Clin Cardiol
Nasir A, Anwar N, Kamran AB, Muhammad A, Haider A, Mubashar M, Tariq F, Helou M, Shami B.   +8 more
europepmc   +1 more source

Rivaroxaban and Piperacillin-Tazobactam: Case of Massive Gastrointestinal Bleeding. [PDF]

Case Rep Med
Mohammadi A, Bitarafan M, Saedian KH, Akhondi H.   +3 more
europepmc   +1 more source

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation. [PDF]

J Am Heart Assoc
Lip GYH, Cheng D, Jiang J, Gao C, Subash R, Vodicka E, Dubey A, Sharma PP, Vettumthara Unnikrishnan A, Mathivanan K, Deitelzweig S.   +10 more
europepmc   +1 more source

Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation. [PDF]

Front Pharmacol
Reis HJ, Costa LBX, Martins GL, Duarte RCF, Costa LCM, Figueiredo EL, Silveira FR, Coelho NG, Carvalho MDG, Vieira LB, Reis EA, Gomes KB, Ferreira CN.   +12 more
europepmc   +1 more source

Effect of rivaroxaban on DNA damage in an ischemia-reperfusion model: Evaluation of 8-OHdG levels. [PDF]

Exp Ther Med
Sayarer C, Erdal CA, Gençpinar T, Gürsoy Doruk Ö, Küme T.   +4 more
europepmc   +1 more source

Efficacy of dual therapy with rivaroxaban and clopidogrel in canine aortic thrombosis resistant to clopidogrel monotherapy: two case reports. [PDF]

J Vet Med Sci
Niijima R, Ishino H.
europepmc   +1 more source

Clinical outcomes observed with Rivaroxaban versus low molecular weight heparin (Enoxaparin) for thrombo-prophylaxis following total knee arthroplasty: a meta-analysis. [PDF]

BMC Cardiovasc Disord
Dai Y, Peng Y, Xia S.
europepmc   +1 more source